BROCHURE
Hilal Arnok is a Assistant Professor,Midwestern University,USA

Hilal Arnok

Assistant Professor

Organizing committee

USA

Midwestern University

BIOGRAPHY

Hilal Arnouk, MD, PhD is an Assistant Professor at the Department of Pathology at Midwestern University. Dr. Arnouk has received his education and post-doctorate training at Roswell Park Cancer Institute, the State University of New York at Buffalo, the Medical College of Georgia and the University of Alabama at Birmingham. He has directed research studies in academia and biotech industry settings. His major areas of expertise include Cancer Immunotherapy, Biomarker Discovery and Regenerative Medicine. Dr. Arnouk also enjoys being an educator for professional students in the medical and biomedical sciences.

PUBLICATIONS

Knight A, Arnouk H, Britt W, Gillespie GY, Cloud GA, et al. (2013) CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ γδ T Cells. PLoS ONE 8(8): e68729. Arnouk H, Lee H, Zhang R, Chung H, Hunt RC, Jahng WJ. Early biosignature of oxidative stress in the retinal pigment epithelium. J Proteomics. (2011) 1; 74(2):254-61. Arnouk H, Zynda E, Wang XY, Hylander B, Manjili M, Repasky E, Subjeck JR and Kazim L (2010) Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo. Int J Hyperthermia. 2010; 26(4):366-75. Lee H, Arnouk H, Sripathi S, Chen P, Zhang R, Bartoli M, Hunt RC, Hrushesky WJ, Chung H, Lee SH, Jahng WJ. Prohibitin as an oxidative stress biomarker in the eye. Int J Biol Macromol. 2010 Dec 1; 47(5):685-90.Int J Biol Macromol. 2010 Aug 1; 47(2):104-8. Lee H, Chung H, Arnouk H, Lamoke F, Hunt RC, Hrushesky WJ, Wood PA, Lee SH, Jahng WJ. Cleavage of the retinal pigment epithelium-specific protein RPE65 under oxidative stress. Int J Biol Macromol. 2010 Aug 1; 47(2):104-8 Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, Langford CP, Arnouk H, Su Y, Haines HL, Suarez-Cuervo C, Lamb LS Jr.Preclinical evaluation of ex vivo expanded/activated gammadelta T cells for immunotherapy of glioblastoma multiforme. J Neurooncol. 2010 Jun 10. Arnouk H, Merkley MA, Podolsky RH, Stöppler H, Álvarez M, Mariategui J, Ferris D, Lee JR, and Dynan WS (2009) Characterization of Molecular Markers Indicative of Cervical Cancer Progression . Proteomics-Clinical Applications, 5: 516-527. Merkley MA, Hildebrandt E, Podolsky RH, Arnouk H, Ferris D, Dynan WS, and Stöppler H (2009) Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 (HPV 16) E6 and E7 oncogenes. Proteome Sci. 23; 7(1):29. Sharma S, Tammela J, Wang X, Arnouk H, Keitz B, Driscoll D, Lele S, Kazim L and Odunsi K. (2007) Characterization of an ovarian tumor specific antigen, Elongation Factor 1 Alpha-2, isolated by panning a synthetic phage-display scFv library with cultured human ovarian cancer cells. Clin Cancer Res 2007; 5889 13(19) Wang XY, Arnouk H, Chen X, Kazim L, Repasky EA and Subjeck JR (2006) Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma. J.Immunology,, 177: 1543-1551 Kulawiec M, Arnouk H, Desouki M, Kazim L, Still I and Singh KK (2006) Proteomic analysis of proteins involved in mitochondria-to-nucleus retrograde response in human cancer cells. Cancer Biology & Therapy; 5(8):967-75. Manjili MH, Arnouk H, Knutson KL, Kazim L, Subjeck JR. (2005) Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce danger signals. (2005) Breast Cancer Res Treat. 7, 1-9 Facciponte JG, Wang XY, Macdonald IJ, Park JE, Arnouk H, Grimm MJ, Li Y,Kim ,Manjili MH, Easton DP, Subjeck JR (2005) Heat shock proteins HSP70 and GP96: structural insights. Cancer Immunol Immunother . 20; 1-8. Manjili MH, Wang XY, MacDonald IJ, Arnouk H, Yang GY, Pritchard MT, Subjeck JR. (2004) Cancer immunotherapy and heat-shock proteins: promises and challenges. Expert Opin Biol Ther. (3): 363-73. Bunworasate U. Arnouk H. Minderman H. O'Loughlin KL. Sait SN. Barcos M. Stewart CC. Baer MR. (2001) Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia. Blood. 98(12): 3492-4

EDUCATION

PhD, (Cancer Pathology, Immunology, Biochemistry and Biophysics) 2005: Roswell Park Cancer Institute, State University of New York at Buffalo

RESEARCH INTEREST

Cancer Biology, Tumor Immunotherapy and Biomarker Discovery.

HONORS AND AWARDS

Arnouk H. Recipient: The University of Alabama at Birmingham Postdoctoral Research Day award (2010). Arnouk H. Recipient: The University of Alabama at Birmingham Postdoctoral Career Enhancement Award (2009) Arnouk H. Recipient: Poster award by The Scientific Research Society Sigma Xi, State University of New York at Buffalo (2005).

COLLABORATIONS

Active collaborations in the fields of Tissue Regeneration, Oncology, Ophthalmology and Immunological Diseases, both in academia and in pharmaceutical industry settings.

EDITORSHIP

Arnouk H. Editorial Board, Journal of Food and Drug Research (2017-Present) Arnouk H. Editorial Board, Journal of Oncology Translational Research (2016-2019) Arnouk H. Biological and Immunotherapy Approaches for Cancer Treatment (2019), ISBN: 978-1-78984-863-2 Arnouk H. Advancements in Tumor Immunotherapy and Cancer Vaccines (2012), ISBN 9789533079981 Arnouk H. Tumor Secreted Grp170 as a Cancer Vaccine (2009), ISBN 9783639159240

Upcoming Conferences